United Therapeutics (UTHR) Misses Q2 EPS by 63c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.27 --0%
Revenue Growth %: -1.2%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -1.2%
Financial Fact:
Income tax expense: -77.3M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $5.85, $0.63 worse than the analyst estimate of $6.48. Revenue for the quarter came in at $714.9 million versus the consensus estimate of $689.93 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
- Active options: TSLA NVDA INTC AAPL SPCX AMD MU AMZN CRWV META
- Popular stocks with increasing option volume: SMCI ORCL GOOGL PLTR GME MSTR SOFI NBIS AVGO HOOD
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
